This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to thePrivacy PolicyandTerms of Use. Please read ourcookie policyfor more information on the use of cookies on this website.
The biopharmaceutical industry is always looking for ways to speed up clinical trial timelines while maintaining patient safety and compliance with regulatory guidelines.
Academic biobanks support preclinical and translational research by collecting, storing, analyzing, and distributing biological samples and associated data to academic and industry researchers.
Clinical samples are used to diagnose disease, guide treatment, and predict patient outcomes. They’re also important for drug discovery and development, where they can be used to track disease stages, look for biomarkers, and develop diagnostic assays.
Repurposing patient samples for multiple non-interventional research studies can maximize sample value and help address the industry-wide problem of patient recruitment.
Modern biomedical research relies on a variety of quality biospecimens annotated with precise and detailed metadata. Consequently, biorepositories must secure excellence in all operations and convey this information to their customers.
Brexit will affect life science research, pharmaceutical regulation, and trading in the UK and Europe. Forward planning will help life sciences transition to a post-Brexit world.